Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
Yves Dauvilliers(Inserm), Jean‐Charles Schwartz(Inserm), Claire-Li Ding(Agence Nationale de Sécurité du Médicament et des Produits de Santé), Gert Jan Lammers(Leiden University Medical Center), Isabelle Arnulf(Centre National de la Recherche Scientifique), Claudio L. Bassetti(Swisscom (Switzerland)), Geert Mayer, Jeanne‐Marie Lecomte(Bioprojet (France)), Philippe Lehert(The University of Melbourne)
Cited by 356
Related Papers
European guideline for the diagnosis and treatment of insomnia
|Journal of Sleep Research|2017|2k
National Sleep Foundation's sleep quality recommendations: first report
|Sleep Health|2016|1.3k
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
|Brain|2019|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Narcolepsy with cataplexy
|The Lancet|2007|716